Valuation: Incyte Corporation

Market Cap 25.03B 21.61B 20.27B 18.47B 34.72B 2,394B 35.2B 238B 93.14B 1,199B 93.98B 91.95B 3,989B P/E 2026 *
54.4x
P/E 2027 * 17.3x
Enterprise Value 20.78B 17.94B 16.83B 15.33B 28.83B 1,987B 29.23B 197B 77.33B 996B 78.03B 76.34B 3,312B EV / Sales 2026 *
3.5x
EV / Sales 2027 * 3.07x
Free-Float
98.15%
Yield 2026 *
-
Yield 2027 * -
1 day+2.78%
1 week+1.60%
Current month+3.33%
1 month+5.33%
3 months+29.58%
6 months+22.08%
Current year+25.04%
1 week 117.56
Extreme 117.56
124.06
1 month 114.5
Extreme 114.505
132.6
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap.
12/8/26 Sell

Chairperson

-10,803 0.0053%
5/8/26 Fiscal year

EVP & Chief Scientific Officer

6,621 0.0033%
5/8/26 Sell

Chairperson

-10,640 0.0052%
Change 5-day change 1-year change 3-year change Capi.($)
+2.78%+1.60%+42.08%+92.34% 25.03B
+0.30%-0.26%+38.86%+1.15% 80.48B
-1.02%-1.34%-2.54%+30.42% 50.63B
-0.32%-5.04%+9.90%+166.83% 47.57B
+17.25%+14.09%-41.83%-41.67% 45.84B
-0.32%+0.98%+50.90%-20.02% 30.9B
+1.80%+7.77%+130.05%-39.33% 25.73B
+1.36%+1.15%-5.15%+207.31% 21.16B
+1.09%+4.94%+64.84%+126.61% 16.75B
+0.04%-5.65%+55.67%+181.20% 15.62B
Average +1.89%-0.15%+34.28%+70.49% 35.97B
Weighted average by Cap. +2.22%-0.34%+26.05%+49.14%

Financials

2026 *2027 *
Net sales 5.94B 5.13B 4.81B 4.38B 8.24B 568B 8.36B 56.42B 22.11B 285B 22.31B 21.83B 947B 6.25B 5.4B 5.06B 4.61B 8.67B 598B 8.79B 59.37B 23.27B 300B 23.48B 22.97B 996B
Net income 472M 407M 382M 348M 654M 45.1B 663M 4.48B 1.76B 22.6B 1.77B 1.73B 75.16B 1.47B 1.27B 1.19B 1.09B 2.04B 141B 2.07B 13.99B 5.48B 70.58B 5.53B 5.41B 235B
Net Debt -4.25B -3.67B -3.44B -3.13B -5.89B -406B -5.98B -40.34B -15.81B -204B -15.95B -15.61B -677B -5.81B -5.02B -4.71B -4.29B -8.06B -556B -8.17B -55.18B -21.62B -278B -21.82B -21.35B -926B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
18/08/26 USD 123.58 +0.07% 33,273
17/08/26 USD 123.50 +2.78% 2,040,676
14/08/26 USD 120.16 -0.30% 785,830
13/08/26 USD 120.52 -0.21% 829,464
12/08/26 USD 120.77 -0.25% 1,055,267
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
123.50USD
Average target price
125.17USD
Spread / Average Target
+1.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock